PROCEPT BioRobotics PRCT
NASDAQ PRCT
$20.38 +0.31 (+1.54%)
As of: Sep 11, 2026 · 3:59 PM EDT

PROCEPT BioRobotics (PRCT) EBITDA Margin Growth (1y) (2021 - 2026)

Analysis

PROCEPT BioRobotics (PRCT) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (1y) (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn -497.00
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn 314.00
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn 124.00
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn 670.00
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn 546.00
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn 264.00
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn -919.00
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn 595.00
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn 146.00
10 PROCEPT BioRobotics 1.17 Bn 895.36 Mn 62.38 Mn -96.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -96.00
Mar 31, 2026 45.00
Dec 31, 2025 -1,175.00
Sep 30, 2025 1,059.00
Jun 30, 2025 2,226.00
Mar 31, 2025 2,241.00
Dec 31, 2024 3,894.00
Sep 30, 2024 3,453.00
Jun 30, 2024 2,712.00
Mar 31, 2024 5,420.00
Dec 31, 2023 3,749.00
Sep 30, 2023 3,567.00
Jun 30, 2023 2,969.00
Mar 31, 2023 -567.00
Dec 31, 2022 6,071.00
Sep 30, 2022 3,901.00
Jun 30, 2022 4,855.00
Mar 31, 2022 4,712.00
Dec 31, 2021 24,401.00
Sep 30, 2021 37,339.00